In both the U.S. and Europe, clinicians want to limit treatment with glucocorticoids — steroid hormones whose long-term use for…
Articles by Marisa Wexler, MS
Galapagos officially has launched a Phase 2 clinical trial that will test its oral therapy GLPG3667 — designed to…
Immpact Bio has been cleared in the U.S. to start testing its cell therapy IMPT-514 in people with active…
Former NFL Super Bowl champ Willie Colon hosted a golf event earlier this week to raise funds for the…
Blooms in the growth of a specific species of gut bacteria, called Ruminococcus blautia gnavus or RG, may trigger disease…
Three new Phase 3 clinical trials testing the experimental therapy ianalumab in people with systemic lupus erythematosus (SLE) and…
CABA-201, an experimental cell therapy for lupus and other autoimmune disorders, has been granted fast track status by the…
Lupkynis (voclosporin) is now approved in Switzerland to treat adults with active lupus nephritis, a complication of lupus characterized…
The Lupus Foundation of America (LFA) is calling on the community to help increase visibility and promote education about…
The Lupus Research Alliance (LRA) is funding four research projects aiming to explore molecular targets that could lead new…